Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet

Covaxin, the homegrown coronavirus vaccine that was authorized for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has...

from NDTV News - Special https://ift.tt/3t6Ri59
via IFTTT